Shijie Cao

机构：Tianjin University of Traditional Chinese Medicine, Cleveland Clinic, Cleveland Clinic Lerner College of Medicine · ORCID：0000-0001-9164-882X

发表论文 63 篇 · 总被引 2475 次 · h-index 26

代表论文

• Natural withanolides, an update (2021 · Natural Product Reports · 被引 75)
• Berberrubine, a Main Metabolite of Berberine, Alleviates Non-Alcoholic Fatty Liver Disease via Modulating Glucose and Lipid Metabolism and Restoring Gut Microbiota (2022 · Frontiers in Pharmacology · 被引 55)
• Incomplete autophagy: Trouble is a friend (2022 · Medicinal Research Reviews · 被引 53)
• Currently Available Strategies for Target Identification of Bioactive Natural Products (2021 · Frontiers in Chemistry · 被引 47)
• Schisandra chinensis lignans improve insulin resistance by targeting TLR4 and activating IRS-1/PI3K/AKT and NF-κB signaling pathways (2024 · International Immunopharmacology · 被引 35)
• Berberine directly targets AKR1B10 protein to modulate lipid and glucose metabolism disorders in NAFLD (2024 · Journal of Ethnopharmacology · 被引 31)